Are nitazenes about to increased drug deaths in the UK?

What is it about?

This Lancet Public Health comment piece warns that nitazenes, a class of highly potent synthetic opioids, represent a serious and growing threat to the UK at a time when drug-related deaths are already at record levels. The authors set out the evidence for nitazene contamination of the UK drug supply, drawing on toxicology data, death notifications and wastewater analysis. The piece situates nitazenes within the broader context of the UK's existing drug-related death crisis, identifying the structural factors that have worsened vulnerability including disinvestment in drug treatment and harm reduction services, increasing poly-drug use and an ageing population of people with opioid dependence. The authors argue that enforcement and tighter scheduling alone cannot address a problem rooted in drug supply contamination and call for low-threshold harm reduction responses, including overdose prevention centres and expanded naloxone distribution, to protect people not in contact with specialist drug services.

Featured Image

Why is it important?

The nitazene threat is urgent and time-sensitive. These synthetic opioids are many times more potent than heroin and have already caused significant overdose mortality in North America. Published in Lancet Public Health in January 2024, this comment piece was among the first to formally sound the alarm about nitazene risk in the UK in a high-impact policy journal, at a moment when the window for preventive action was still open. The authors make an explicit and politically pointed argument: that stigma and opposition to harm reduction interventions, including overdose prevention centres, are creating preventable deaths. The piece connects directly to research on drug consumption rooms and overdose prevention, and strengthens the public health case for the policy reforms.